<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7168643\results\search\disease\results.xml">
  <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Seasonal" exact="influenza" post="epidemics remain one of the largest public health burdens"/>
  <result pre="The best and most effective strategy to date in preventing" exact="influenza" post="infection is a worldwide vaccination campaign. Currently, two vaccines"/>
  <result pre="vaccines are available to the public for the treatment of" exact="influenza" post="infection, the chemically Inactivated Influenza Vaccine (IIV) and the"/>
  <result pre="attenuate the LAIV. In this study, we demonstrate that the" exact="influenza" post="A virus (IAV) master donor virus (MDV) A/Ann Arbor/6/60"/>
  <result pre="improve the efficacy of the current IAV LAIV. live attenuated" exact="influenza" post="vaccine influenza master donor virus virus–host interaction vaccine safety"/>
  <result pre="efficacy of the current IAV LAIV. live attenuated influenza vaccine" exact="influenza" post="master donor virus virus–host interaction vaccine safety immunogenicity protection"/>
  <result pre="virus–host interaction vaccine safety immunogenicity protection efficacy 1. Introduction The" exact="influenza" post="A virus (IAV) belongs to the Orthomyxoviridae family of"/>
  <result pre="is considered the most effective approach to protect against seasonal" exact="influenza" post="infections. However, despite worldwide vaccination plans, seasonal influenza is"/>
  <result pre="against seasonal influenza infections. However, despite worldwide vaccination plans, seasonal" exact="influenza" post="is still responsible for 1 billion infections, causing 3–5"/>
  <result pre="vaccine match those present in the seasonally circulating virus. Inactivated" exact="influenza" post="vaccines (IIVs), which induce limited T cell-mediated immune responses"/>
  <result pre="the circulating strains [6,7]. On the other hand, live attenuated" exact="influenza" post="vaccines (LAIVs) usually induce more robust adaptive B- and"/>
  <result pre="immune responses associated with better protection against homologous and heterologous" exact="influenza" post="viruses [5,6,7]. Despite the multiple advantages of LAIVs, the"/>
  <result pre="5C,D, respectively). C57BL/6 mice are a validated animal model of" exact="influenza" post="infection, which has been used previously to evaluate IAV"/>
  <result pre="to evaluate IAV virulence, attenuation, and/or protection efficacy of new" exact="influenza" post="vaccines [17,18,26,27,40,41]. None of the viruses caused weight loss,"/>
  <result pre="low immunogenicity, should be evaluated in other animal models of" exact="influenza" post="infection. For instance, the implication in virus transmission should"/>
  <result pre="in ferrets or guinea pigs, both well-stablished animal models of" exact="influenza" post="virus infection and transmission [43,44,45,46]. The current MDV A/AA/6/60"/>
  <result pre="Vaccination is the best way to prevent the spread of" exact="influenza" post="and reduce the global health burden. However, in recent"/>
  <result pre="strategies that are being currently developed for the treatment of" exact="influenza" post="viral infections. 4. Materials and Methods 4.1. Cells and"/>
  <result pre="for 1 h at room temperature and incubated with the" exact="influenza" post="virus NP mAb HB-65 (ATCC) [18,40,52] for 1 h"/>
  <result pre="at 21 days p.i. and evaluated for the presence of" exact="influenza" post="virus-specific antibodies by ELISA [18,40]. Briefly, 96-well plates were"/>
  <result pre="Rep.20186718018510.15585/mmwr.mm6706a229447141 5.MameliC.D’AuriaE.ErbaP.NanniniP.ZuccottiG.V.Influenza vaccine response: Future perspectivesExpert Opin. Biol. Ther.2018181510.1080/14712598.2018.1391786 6.BelongiaE.A.SimpsonM.D.KingJ.P.SundaramM.E.KelleyN.S.OsterholmM.T.McLeanH.Q.Variable" exact="influenza" post="vaccine effectiveness by subtype: A systematic review and meta-analysis"/>
  <result pre="test-negative design studiesLancet Infect. Dis.20161694295110.1016/S1473-3099(16)00129-827061888 7.DarvishianM.BijlsmaM.J.HakE.van den HeuvelE.R.Effectiveness of seasonal" exact="influenza" post="vaccine in community-dwelling elderly people: a meta-analysis of test-negative"/>
  <result pre="design case-control studiesLancet Infect. Dis.2014141228123910.1016/S1473-3099(14)70960-025455990 8.BergenR.BlackS.ShinefieldH.LewisE.RayP.HansenJ.WalkerR.HesselC.CordovaJ.MendelmanP.M.Safety of cold-adapted live attenuated" exact="influenza" post="vaccine in a large cohort of children and adolescentsPediatr"/>
  <result pre="children and adolescentsPediatr Infect. Dis. J.20042313814410.1097/01.inf.0000109392.96411.4f14872180 9.JinH.ChenZ.Production of live attenuated" exact="influenza" post="vaccines against seasonal and potential pandemic influenza virusesCurr. Opin."/>
  <result pre="of live attenuated influenza vaccines against seasonal and potential pandemic" exact="influenza" post="virusesCurr. Opin. Virol.20146343910.1016/j.coviro.2014.02.00824705137 10.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes in the"/>
  <result pre="Virol.20146343910.1016/j.coviro.2014.02.00824705137 10.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes in the cold-adapted, live attenuated" exact="influenza" post="vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 11.ChanW.ZhouH.KembleG.JinH.The cold adapted and"/>
  <result pre="strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 11.ChanW.ZhouH.KembleG.JinH.The cold adapted and temperature sensitive" exact="influenza" post="A/Ann Arbor/6/60 virus, the master donor virus for live"/>
  <result pre="A/Ann Arbor/6/60 virus, the master donor virus for live attenuated" exact="influenza" post="vaccines, has multiple defects in replication at the restrictive"/>
  <result pre="temperatureVirology200838030431110.1016/j.virol.2008.07.02718768193 12.SnyderM.H.BettsR.F.DeBordeD.TierneyE.L.ClementsM.L.HerringtonD.SearsS.D.DolinR.MaassabH.F.MurphyB.R.Four viral genes independently contribute to attenuation of live" exact="influenza" post="A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccinesJ. Virol.19886248849510.1128/JVI.62.2.488-495.19883336068 13.Garcia-SastreA.EgorovA.MatassovD.BrandtS.LevyD.E.DurbinJ.E.PaleseP.MusterT.Influenza"/>
  <result pre="gene replicates in interferon-deficient systemsVirology199825232433010.1006/viro.1998.95089878611 14.HaleB.G.RandallR.E.OrtinJ.JacksonD.The multifunctional NS1 protein of" exact="influenza" post="A virusesJ. Gen. Virol.2008892359237610.1099/vir.0.2008/004606-018796704 15.JaggerB.W.WiseH.M.KashJ.C.WaltersK.A.WillsN.M.XiaoY.L.DunfeeR.L.SchwartzmanL.M.OzinskyA.BellG.L.et al.An overlapping protein-coding region"/>
  <result pre="A virusesJ. Gen. Virol.2008892359237610.1099/vir.0.2008/004606-018796704 15.JaggerB.W.WiseH.M.KashJ.C.WaltersK.A.WillsN.M.XiaoY.L.DunfeeR.L.SchwartzmanL.M.OzinskyA.BellG.L.et al.An overlapping protein-coding region in" exact="influenza" post="A virus segment 3 modulates the host responseScience201233719920410.1126/science.122221322745253 16.NogalesA.Martinez-SobridoL.TophamD.J.DeDiegoM.L.Modulation"/>
  <result pre="acids at the C-terminus of PA-X are associated with increased" exact="influenza" post="A virus replication and pathogenicityJ. Gen. Virol.2015962036204910.1099/vir.0.00014325877935 20.GaoH.XuG.SunY.QiL.WangJ.KongW.SunH.PuJ.ChangK.C.LiuJ.PA-X is"/>
  <result pre="Gen. Virol.2015962036204910.1099/vir.0.00014325877935 20.GaoH.XuG.SunY.QiL.WangJ.KongW.SunH.PuJ.ChangK.C.LiuJ.PA-X is a virulence factor in avian H9N2" exact="influenza" post="virusJ. Gen. Virol.2015962587259410.1099/jgv.0.00023226296365 21.HuJ.MoY.WangX.GuM.HuZ.ZhongL.WuQ.HaoX.HuS.LiuW.et al.PA-X decreases the pathogenicity of"/>
  <result pre="Virol.2015962587259410.1099/jgv.0.00023226296365 21.HuJ.MoY.WangX.GuM.HuZ.ZhongL.WuQ.HaoX.HuS.LiuW.et al.PA-X decreases the pathogenicity of highly pathogenic H5N1" exact="influenza" post="A virus in avian species by inhibiting virus replication"/>
  <result pre="Influenza A Virus PA-X Host Shutoff ProteinPLoS Pathog.201612e100542710.1371/journal.ppat.100542726849127 24.BavagnoliL.CucuzzaS.CampaniniG.RovidaF.PaolucciS.BaldantiF.MagaG.The novel" exact="influenza" post="A virus protein PA-X and its naturally deleted variant"/>
  <result pre="mechanisms, and consequencesJ. Interferon Cytokine Res.20092954955710.1089/jir.2009.006619708812 29.DasK.MaL.C.XiaoR.RadvanskyB.AraminiJ.ZhaoL.MarklundJ.KuoR.L.TwuK.Y.ArnoldE.et al.Structural basis for" exact="suppression" post="of a host antiviral response by influenza A virusProc."/>
  <result pre="al.Structural basis for suppression of a host antiviral response by" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA2008105130931309810.1073/pnas.080521310518725644 30.KochsG.Garcia-SastreA.Martinez-SobridoL.Multiple anti-interferon actions"/>
  <result pre="virusProc. Natl. Acad. Sci. USA2008105130931309810.1073/pnas.080521310518725644 30.KochsG.Garcia-SastreA.Martinez-SobridoL.Multiple anti-interferon actions of the" exact="influenza" post="A virus NS1 proteinJ. Virol.2007817011702110.1128/JVI.02581-0617442719 31.NoahD.L.TwuK.Y.KrugR.M.Cellular antiviral responses against"/>
  <result pre="influenza A virus NS1 proteinJ. Virol.2007817011702110.1128/JVI.02581-0617442719 31.NoahD.L.TwuK.Y.KrugR.M.Cellular antiviral responses against" exact="influenza" post="A virus are countered at the posttranscriptional level by"/>
  <result pre="pre-mRNASVirology200330738639510.1016/S0042-6822(02)00127-712667806 32.AyllonJ.DominguesP.RajsbaumR.MiorinL.SchmolkeM.HaleB.G.Garcia-SastreA.A single amino acid substitution in the novel H7N9" exact="influenza" post="A virus NS1 protein increases CPSF30 binding and virulenceJ."/>
  <result pre="Cell19981991100010.1016/S1097-2765(00)80099-49651582 34.TwuK.Y.NoahD.L.RaoP.KuoR.L.KrugR.M.The CPSF30 binding site on the NS1A protein of" exact="influenza" post="A virus is a potential antiviral targetJ. Virol.2006803957396510.1128/JVI.80.8.3957-3965.200616571812 35.SteidleS.Martinez-SobridoL.MordsteinM.LienenklausS.Garcia-SastreA.StaheliP.KochsG.Glycine"/>
  <result pre="35.SteidleS.Martinez-SobridoL.MordsteinM.LienenklausS.Garcia-SastreA.StaheliP.KochsG.Glycine 184 in nonstructural protein NS1 determines the virulence of" exact="influenza" post="A virus strain PR8 without affecting the host interferon"/>
  <result pre="control of host gene expression by the 2009 pandemic H1N1" exact="influenza" post="A virus NS1 proteinJ. Virol.2010846909692210.1128/JVI.00081-1020444891 39.LeeJ.YuH.LiY.MaJ.LangY.DuffM.HenningsonJ.LiuQ.LiY.NagyA.et al.Impacts of different"/>
  <result pre="Vis. Exp.201710.3791/55898 42.GuoH.SantiagoF.LambertK.TakimotoT.TophamD.J.T cell-mediated protection against lethal 2009 pandemic H1N1" exact="influenza" post="virus infection in a mouse modelJ. Virol.20118544845510.1128/JVI.01812-1020980523 43.BakerS.F.GuoH.AlbrechtR.A.Garcia-SastreA.TophamD.J.Martinez-SobridoL.Protection against"/>
  <result pre="virus infection in a mouse modelJ. Virol.20118544845510.1128/JVI.01812-1020980523 43.BakerS.F.GuoH.AlbrechtR.A.Garcia-SastreA.TophamD.J.Martinez-SobridoL.Protection against lethal" exact="influenza" post="with a viral mimicJ. Virol.2013878591860510.1128/JVI.01081-1323720727 44.BelserJ.A.Pulit-PenalozaJ.A.MainesT.R.Ferreting Out Influenza Virus"/>
  <result pre="Influenza Vaccine into a Pathogenic VirusJ. Virol.2016908454846310.1128/JVI.00163-1627440882 48.QuinlivanM.ZamarinD.Garcia-SastreA.CullinaneA.ChambersT.PaleseP.Attenuation of equine" exact="influenza" post="viruses through truncations of the NS1 proteinJ. Virol.2005798431843910.1128/JVI.79.13.8431-8439.200515956587 49.NogalesA.RodriguezL.ChaucheC.HuangK.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez-SobridoL.Temperature-Sensitive"/>
  <result pre="Live-Attenuated Canine Influenza Virus H3N8 VaccineJ. Virol.20179110.1128/JVI.02211-16 50.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated" exact="influenza" post="vaccine for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 51.NogalesA.Martinez-SobridoL.Reverse Genetics Approaches"/>
  <result pre="VaccineJ. Virol.20179110.1128/JVI.02211-16 50.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine" exact="influenza" post="virusVirology20175049610610.1016/j.virol.2017.01.02028167384 51.NogalesA.Martinez-SobridoL.Reverse Genetics Approaches for the Development of Influenza"/>
  <result pre="for the Development of Influenza VaccinesInt. J. Mol. Sci.2016182010.3390/ijms18010020 52.NogalesA.BakerS.F.Martinez-SobridoL.Replication-competent" exact="influenza" post="A viruses expressing a red fluorescent proteinVirology201547620621610.1016/j.virol.2014.12.00625553516 53.SolorzanoA.WebbyR.J.LagerK.M.JankeB.H.Garcia-SastreA.RichtJ.A.Mutations in"/>
  <result pre="red fluorescent proteinVirology201547620621610.1016/j.virol.2014.12.00625553516 53.SolorzanoA.WebbyR.J.LagerK.M.JankeB.H.Garcia-SastreA.RichtJ.A.Mutations in the NS1 protein of swine" exact="influenza" post="virus impair anti-interferon activity and confer attenuation in pigsJ."/>
  <result pre="1 Ability of master donor virus (MDV) A/AA/6/60 live attenuated" exact="influenza" post="vaccine (LAIV) PA and NS1 proteins to block host"/>
 </snippets>
</snippetsTree>
